These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36311686)

  • 1. Cerebrospinal fluid neurofilament light chain as a potential prognostic biomarker for leptomeningeal metastasis.
    Hyun JW; Kim Y; Kim KH; Kim SH; Park EY; Youn JH; Yoo H; Gwak HS; Kim HJ
    Oncol Lett; 2022 Dec; 24(6):428. PubMed ID: 36311686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
    Peng L; Bi C; Xia D; Mao L; Qian H
    Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.
    Gaetani L; Eusebi P; Mancini A; Gentili L; Borrelli A; Parnetti L; Calabresi P; Sarchielli P; Blennow K; Zetterberg H; Di Filippo M
    Mult Scler Relat Disord; 2019 Oct; 35():228-232. PubMed ID: 31404762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid neurofilament light chain predicts short-term prognosis in pediatric Guillain-Barré syndrome.
    Jin M; Liu K; Zhao L; Liu J; Zhao Z; Zhao Y; Sun S
    Front Neurol; 2022; 13():972367. PubMed ID: 36071910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus.
    Margraf NG; Dargvainiene J; Theel E; Leypoldt F; Lieb W; Franke A; Berger K; Kuhle J; Kuhlenbaeumer G
    J Neurol; 2023 Apr; 270(4):2128-2138. PubMed ID: 36624182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia.
    Kessler C; Serna-Higuita LM; Rattay TW; Maetzler W; Wurster I; Hayer S; Wilke C; Hengel H; Reichbauer J; Armbruster M; Schöls L; Martus P; Schüle R
    Ann Clin Transl Neurol; 2021 May; 8(5):1122-1131. PubMed ID: 33819388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis.
    Hyun JW; Park JH; Kang BG; Park EY; Park B; Joo J; Kim JK; Kim SH; Jeong JH; Lee HW; Park KD; Choi KG; Hwang SH; Gwak HS; Kim HJ
    Oncotarget; 2017 Aug; 8(32):53326-53335. PubMed ID: 28881814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
    Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
    Front Immunol; 2021; 12():719432. PubMed ID: 34975832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.
    Kern S; Syrjanen JA; Blennow K; Zetterberg H; Skoog I; Waern M; Hagen CE; van Harten AC; Knopman DS; Jack CR; Petersen RC; Mielke MM
    JAMA Neurol; 2019 Feb; 76(2):187-193. PubMed ID: 30419087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.
    Gil-Perotin S; Castillo-Villalba J; Cubas-Nuñez L; Gasque R; Hervas D; Gomez-Mateu J; Alcala C; Perez-Miralles F; Gascon F; Dominguez JA; Casanova B
    Front Neurol; 2019; 10():1008. PubMed ID: 31608004
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurofilament light chain: a biomarker for genetic frontotemporal dementia.
    Meeter LH; Dopper EG; Jiskoot LC; Sanchez-Valle R; Graff C; Benussi L; Ghidoni R; Pijnenburg YA; Borroni B; Galimberti D; Laforce RJ; Masellis M; Vandenberghe R; Ber IL; Otto M; van Minkelen R; Papma JM; Rombouts SA; Balasa M; Öijerstedt L; Jelic V; Dick KM; Cash DM; Harding SR; Jorge Cardoso M; Ourselin S; Rossor MN; Padovani A; Scarpini E; Fenoglio C; Tartaglia MC; Lamari F; Barro C; Kuhle J; Rohrer JD; Teunissen CE; van Swieten JC
    Ann Clin Transl Neurol; 2016 Aug; 3(8):623-36. PubMed ID: 27606344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Shi J; Qin X; Chang X; Wang H; Guo J; Zhang W
    J Cell Mol Med; 2022 Jan; 26(2):583-587. PubMed ID: 34866307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen.
    Rich KA; Fox A; Yalvac M; Heintzman S; Tellez M; Bartlett A; Severyn S; Linsenmayer M; Kelly K; Reynolds J; Sterling GB; Weaver T; Rajneesh K; Pino MG; Arnold WD; Elsheikh B; Kolb SJ
    J Neuromuscul Dis; 2022; 9(1):111-119. PubMed ID: 34776417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.
    Braun M; Bjurnemark C; Seo W; Freyhult E; Nyholm D; Niemelä V; Blennow K; Zetterberg H; Fällmar D; Kultima K; Virhammar J
    Fluids Barriers CNS; 2022 Feb; 19(1):15. PubMed ID: 35164790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model.
    Dreger M; Steinbach R; Gaur N; Metzner K; Stubendorff B; Witte OW; Grosskreutz J
    Front Neurosci; 2021; 15():651651. PubMed ID: 33889072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study.
    Cai L; Huang J
    Neuropsychiatr Dis Treat; 2018; 14():2241-2254. PubMed ID: 30214214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS.
    Kasai T; Kojima Y; Ohmichi T; Tatebe H; Tsuji Y; Noto YI; Kitani-Morii F; Shinomoto M; Allsop D; Mizuno T; Tokuda T
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2489-2502. PubMed ID: 31742901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.